Patents by Inventor Takae Okada

Takae Okada has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9139881
    Abstract: The present invention aims to provide a method for determining breast cancer susceptibility, in which a DNA copy number polymorphism associated with breast cancer susceptibility is identified and determination is made based on an increase or decrease in the DNA copy number polymorphism. The present invention attempts to achieve this by performing microarray assay using the peripheral blood of sporadic breast cancer patients, identifying a DNA copy number polymorphism associated with breast cancer susceptibility in a chromosomal region, detecting the number of copies of the above DNA copy number polymorphism by quantitative PCR, and then determining breast cancer susceptibility based on an increase or decrease in the DNA copy number polymorphism.
    Type: Grant
    Filed: October 26, 2011
    Date of Patent: September 22, 2015
    Assignee: Yamaguchi University
    Inventors: Yutaka Suehiro, Kohsuke Sasaki, Yuji Hinoda, Takae Okada
  • Publication number: 20150111769
    Abstract: The present invention aims to provide an assessment method of corpus uteri cancer susceptibility, in which a human chromosomal region consisting of a nucleotide sequence of approximately 100 bps that exhibits a DNA copy number polymorphism associated with corpus uteri cancer susceptibility is identified and assessment is made based on an increase or decrease in the DNA copy number polymorphism.
    Type: Application
    Filed: April 5, 2013
    Publication date: April 23, 2015
    Applicant: YAMAGUCHI UNIVERSITY
    Inventors: Yutaka Suehiro, Kohsuke Sasaki, Takae Okada
  • Publication number: 20130210012
    Abstract: The present invention aims to provide a method for determining breast cancer susceptibility, in which a DNA copy number polymorphism associated with breast cancer susceptibility is identified and determination is made based on an increase or decrease in the DNA copy number polymorphism. The present invention attempts to achieve this by performing microarray assay using the peripheral blood of sporadic breast cancer patients, identifying a DNA copy number polymorphism associated with breast cancer susceptibility in a chromosomal region, detecting the number of copies of the above DNA copy number polymorphism by quantitative PCR, and then determining breast cancer susceptibility based on an increase or decrease in the DNA copy number polymorphism.
    Type: Application
    Filed: October 26, 2011
    Publication date: August 15, 2013
    Applicant: YAMAGUCHI UNIVERSITY
    Inventors: Yutaka Suehiro, Kohsuke Sasaki, Yuji Hinoda, Takae Okada